Literature DB >> 19944977

Immunotherapy combined with chemotherapy in the treatment of tumors.

James L Frazier1, James E Han, Michael Lim, Alessandro Olivi.   

Abstract

This article provides a broad overview of the data, including laboratory and clinical studies, currently available on the combination of immunotherapy and chemotherapy for treating cancer. The various forms of immunotherapy combined with chemotherapy include monoclonal antibodies, adoptive lymphocyte transfer, or active specific immunotherapy, such as tumor proteins, irradiated tumor cells, tumor cell lysates, dendritic cells pulsed with peptides or lysates, or tumor antigens expressed in plasmids or viral vectors. This discussion is not limited to malignant brain tumors, because many of the studies have been conducted on various cancer types, thereby providing a comprehensive perspective that may encourage further studies that combine chemotherapy and immunotherapy for treating brain tumors.

Entities:  

Mesh:

Year:  2010        PMID: 19944977     DOI: 10.1016/j.nec.2009.09.003

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  9 in total

Review 1.  Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

Authors:  Vijaya B Joshi; Sean M Geary; Brett P Gross; Amaraporn Wongrakpanich; Lyse A Norian; Aliasger K Salem
Journal:  Expert Rev Vaccines       Date:  2014-01       Impact factor: 5.217

Review 2.  Therapeutic cancer vaccines in combination with conventional therapy.

Authors:  Mads Hald Andersen; Niels Junker; Eva Ellebaek; Inge Marie Svane; Per Thor Straten
Journal:  J Biomed Biotechnol       Date:  2010-06-29

3.  Advances in cellular therapy for the treatment of thyroid cancer.

Authors:  Claudia Papewalis; Margret Ehlers; Matthias Schott
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

4.  Trends in cancer immunotherapy.

Authors:  Joseph F Murphy
Journal:  Clin Med Insights Oncol       Date:  2010-07-14

5.  A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain.

Authors:  Jacob Ruzevick; Sarah Nicholas; Kristin Redmond; Lawrence Kleinberg; Evan J Lipson; Michael Lim
Journal:  Case Rep Oncol Med       Date:  2013-12-08

6.  Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma.

Authors:  Ying Li; Jiani Yuan; Qian Yang; Wei Cao; Xuanxuan Zhou; Yanhua Xie; Honghai Tu; Ya Zhang; Siwang Wang
Journal:  Int J Nanomedicine       Date:  2014-12-04

7.  Laricitrin ameliorates lung cancer-mediated dendritic cell suppression by inhibiting signal transducer and activator of transcription 3.

Authors:  Wei-An Chang; Jen-Yu Hung; Shu-Fang Jian; Yi-Shiuan Lin; Cheng-Ying Wu; Ya-Ling Hsu; Po-Lin Kuo
Journal:  Oncotarget       Date:  2016-12-20

8.  Effects of dasatinib on CD8+T, Th1, and Treg cells in patients with chronic myeloid leukemia.

Authors:  Xiaoqing Wei; Lin He; Xiaodong Wang; Min Lin; Jingying Dai
Journal:  J Int Med Res       Date:  2019-10-03       Impact factor: 1.671

Review 9.  Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.

Authors:  Eileen S Kim; Jennifer E Kim; Mira A Patel; Antonella Mangraviti; Jacob Ruzevick; Michael Lim
Journal:  J Immunol Res       Date:  2016-01-04       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.